Abstract: Since the inception of the China Innovation and Entrepreneurship Competition in 2012, the China Innovation and Entrepreneurship Competition has been held for 10 consecutive sessions, with a total of more than 240,000 enterprises and teams registering to participate, and has developed into the most influential innovation and entrepreneurship brand activity in China, and has also become the largest maker space and the strongest platform for public support in China.
Scientific and technological innovation, achievements in great causes. From October 12th to 13th, the 10th China Innovation and Entrepreneurship Competition Biomedicine National Competition was grandly opened in Hangzhou High-tech Zone. In the opening speech, Zhang Weixing, secretary of the Party Committee of the Torch Center of the Ministry of Science and Technology, said that the competition takes the discovery, cultivation and service of science and technology innovation enterprises as its mission, and is committed to promoting various innovative elements to gather together to enterprises and empowering technological innovation for enterprises.
As the first national competition, a total of 4931 elite enterprises in the field competed in the biomedical field, and 340 enterprises were finally shortlisted for the biomedical national competition after the competition of 37 local divisions across the country and the recommendation of the provincial science and technology management department. The project covers important areas of the biomedical industry such as precision medicine, new oncology therapies, new anti-cancer drugs, and biotechnology. The participating enterprises compete on the same stage in different subdivision technologies and different application scenarios, and through the "racecourse" of scientific and technological innovation, they learn from each other, learn from each other's strengths, and improve together.
Xuanjia Bio won the first prize in the biomedical industry competition in local competitions and was shortlisted for the national competition of China Innovation and Entrepreneurship Competition. In the national competition, the shortlisted project "Supramolecular Biocatalysis Technology and Its Industrialization" won unanimous praise from the on-site jury for its high-quality project background, solid technical advantages and perfect development plan.
The company's scientific research team led by Professor Zhang Jiaheng of Harbin Institute of Technology (Shenzhen) has made repeated breakthroughs in academic research in the field of biomedicine, and has published in Advanced Functional Materials "The combination of supramolecular solvents and microemulsions - 49 times more soluble in drugs and 4 times more efficient in transdermal delivery"; Journal of the American Chemical Society, Nature Communications, ACS Applied Materials and Interfaces, and Journal of Chemical Engineering. And other international top journals and magazines have published the relevant research results of "important research progress in the fields of energetic materials and sterilization and epidemic prevention".
Xuanjia Bio has been continuously and deeply implementing the innovation-driven development strategy, focusing on technology research and development, and has made great progress and industrialization experience in the field of supramolecular research. Since its inception, the company has won the China Youth Innovation and Entrepreneurship Competition National Competition Gold Award, "China Chuangyi" National Competition Third Prize, Guangdong Zhongchuang Cup Gold Award and many other awards, and was awarded the title of "National Excellent Innovation and Entrepreneurship Project" by the Ministry of Human resources and Social Security.
Xuanjia Bio focuses on the innovation and application of "supramolecular modification technology", and its business scope covers R&D, production and customization services in the fields of biomedicine, daily chemicals and health food.
Adhering to the concept of exploring life sciences with advanced materials, we are committed to becoming an influential new material technology and biotechnology first-class enterprise in the world, and promoting the high-quality development of the life and health industry.